Approvals/CIMA-AEMPS/PALGESIC RETARD 250 MG COMPRIMIDOS DE LIBERACIÓN PROLONGADA EFG

Approved

STANDARD

PALGESIC RETARD 250 MG COMPRIMIDOS DE LIBERACIÓN PROLONGADA EFG

Kern Pharma S.L.🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: 94df75d5f4a45284
Drug Cima Aemps Name: PALGESIC RETARD 250 MG COMPRIMIDOS DE LIBERACIÓN PROLONGADA EFG
Register Number: 88332
Holder Company Name: Kern Pharma S.L.
Marketing Company Name: Kern Pharma S.L.
Holder Company Detail Path: /organization/kern-pharma-s-l
Marketing Company Detail Path: /organization/kern-pharma-s-l
Authorization Date: 2022-11-28
Dosage Form: COMPRIMIDO DE LIBERACIÓN PROLONGADA
Dose: 250 mg
Route Of Administration: VÍA ORAL
Prescription Type: Medicamento Sujeto A Prescripción Médica. Estupefacientes
Commercialized: Yes
Company Name: Kern Pharma S.L.
Company Detail Path: /organization/kern-pharma-s-l

TAPENTADOL FOSFATO

382,84 mg

Approved

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Nov 28, 2022

Approval ID

94df75d5f4a45284

Type

Standard